Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.61.
EARNINGS PER SHARE (EPS)
N/A
EARNINGS PER SHARE (EPS) AVG TTM
-0.64
EARNINGS PER SHARE (EPS) AVG 3Y
-4.21
EARNINGS PER SHARE (EPS) AVG 5Y
-9.38
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Connect Biopharma Holdings Limited
Market Cap
$60.32M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.64
3Y Avg
-4.21
5Y Avg
-9.38
Market Cap
$60.24M
Earnings Per Share (EPS)
-0.64
TTM Avg
-0.89
3Y Avg
-1.15
5Y Avg
-1.02
Market Cap
$60.12M
Earnings Per Share (EPS)
-0.27
TTM Avg
-0.26
3Y Avg
-0.31
5Y Avg
-0.32
Market Cap
$59.23M
Earnings Per Share (EPS)
-13.20
TTM Avg
-15.24
3Y Avg
-17.58
5Y Avg
-15.68
Market Cap
$61.23M
Earnings Per Share (EPS)
N/A
TTM Avg
-19.12
3Y Avg
-29.60
5Y Avg
-38.42
Market Cap
$58.34M
Earnings Per Share (EPS)
-2.39
TTM Avg
-2.92
3Y Avg
-5.17
5Y Avg
-5.77
Market Cap
$57.87M
Earnings Per Share (EPS)
N/A
TTM Avg
-3.23
3Y Avg
-2.68
5Y Avg
-2.37
Market Cap
$63.14M
Earnings Per Share (EPS)
-1.09
TTM Avg
-1.47
3Y Avg
-0.85
5Y Avg
-0.92
Market Cap
$63.30M
Earnings Per Share (EPS)
-2.02
TTM Avg
-7.29
3Y Avg
-26.82
5Y Avg
-38.33
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Connect Biopharma Holdings Limited (CNTB) | $60.32M | N/A | -0.64 | -4.21 | -9.38 |
| PDS Biotechnology Corporation (PDSB)vs › | $60.24M | -0.64 | -0.89 | -1.15 | -1.02 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.12M | -0.27 | -0.26 | -0.31 | -0.32 |
| Fractyl Health, Inc. (GUTS)vs › | $59.23M | -13.20 | -15.24 | -17.58 | -15.68 |
| Adicet Bio, Inc. (ACET)vs › | $61.23M | N/A | -19.12 | -29.60 | -38.42 |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.34M | -2.39 | -2.92 | -5.17 | -5.77 |
| Boundless Bio, Inc. (BOLD)vs › | $57.87M | N/A | -3.23 | -2.68 | -2.37 |
| InterCure Ltd. (INCR)vs › | $63.14M | -1.09 | -1.47 | -0.85 | -0.92 |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.30M | -2.02 | -7.29 | -26.82 | -38.33 |
| Alps Group Inc (ALPS)vs › | $63.23M | N/A | -0.02 | -0.02 | -0.01 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
$-1.00
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.00 |
| 2024-12-31 | -0.28 |
| 2023-12-31 | -1.08 |
| 2022-12-31 | -14.50 |
| 2021-12-31 | -25.00 |
| 2020-12-31 | -14.45 |
| 2019-12-31 | -3.02 |
